Actinium Pharmaceuticals reported $37.74M in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
AbbVie USD 33.67B 140M Jun/2026
Actinium Pharmaceuticals USD 37.74M 5.52M Jun/2026
Amgen USD 34.96B 3.49B Jun/2026
Bioline Rx USD 21.58M 2.1M Mar/2026
Capricor Therapeutics USD 242.13M 40.96M Jun/2026
Pfizer USD 41.36B 1.46B Jun/2026